BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33169673)

  • 1. Integrated analysis of the functions of RNA binding proteins in clear cell renal cell carcinoma.
    Hua X; Chen J; Ge S; Xiao H; Zhang L; Liang C
    Genomics; 2021 Jan; 113(1 Pt 2):850-860. PubMed ID: 33169673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a prognostic model of RNA binding proteins in clear cell renal carcinoma.
    Han W; Fan B; Huang Y; Wang X; Zhang Z; Gu G; Liu Z
    BMC Nephrol; 2022 May; 23(1):172. PubMed ID: 35513791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of prognostic signature based on RNA binding proteins related genes analysis in clear cell renal cell carcinoma.
    Chen Q; Li ZL; Fu SQ; Wang SY; Liu YT; Ma M; Yang XR; Xie WJ; Gong BB; Sun T
    Aging (Albany NY); 2021 Jan; 13(3):3926-3944. PubMed ID: 33461173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
    Qin X; Liu Z; Yan K; Fang Z; Fan Y
    Int J Med Sci; 2021; 18(4):953-963. PubMed ID: 33456353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a prognostic model for kidney renal clear cell carcinoma based on RNA binding protein expression.
    Xiang Y; Zhou S; Hao J; Zhong C; Ma Q; Sun Z; Wei C
    Aging (Albany NY); 2020 Nov; 12(24):25356-25372. PubMed ID: 33229623
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lin W; Chen X; Chen T; Liu J; Ye Y; Chen L; Qiu X; Chia-Hsien Cheng J; Zhang L; Wu J; Qiu S
    DNA Cell Biol; 2020 Jun; 39(6):1000-1011. PubMed ID: 32282241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression network analysis identified FCER1G in association with progression and prognosis in human clear cell renal cell carcinoma.
    Chen L; Yuan L; Wang Y; Wang G; Zhu Y; Cao R; Qian G; Xie C; Liu X; Xiao Y; Wang X
    Int J Biol Sci; 2017; 13(11):1361-1372. PubMed ID: 29209141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
    Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
    Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
    Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
    Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell Carcinoma.
    Zhang D; Wang Y; Hu X
    DNA Cell Biol; 2020 Oct; 39(10):1799-1812. PubMed ID: 32716214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma.
    Liu Y; Cheng G; Song Z; Xu T; Ruan H; Cao Q; Wang K; Bao L; Liu J; Zhou L; Liu D; Yang H; Chen K; Zhang X
    Int J Oncol; 2019 Sep; 55(3):645-656. PubMed ID: 31364727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
    Jin Y; Qin X
    DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Analysis of the Roles of RNA Binding Proteins and Their Prognostic Value in Clear Cell Renal Cell Carcinoma.
    Wang B; Zhao H; Ni S; Ding B
    J Healthc Eng; 2021; 2021():5568411. PubMed ID: 34306592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
    Wu G; Wang Q; Xu Y; Li Q; Cheng L
    Aging (Albany NY); 2020 Jul; 12(14):14933-14948. PubMed ID: 32688345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression Network Analysis Identifies Fourteen Hub Genes Associated with Prognosis in Clear Cell Renal Cell Carcinoma.
    Chen JY; Sun Y; Qiao N; Ge YY; Li JH; Lin Y; Yao SL
    Curr Med Sci; 2020 Aug; 40(4):773-785. PubMed ID: 32862390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
    Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
    Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.